Veracyte (VCYT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
Image source: The Motley Fool. DATE Wednesday, Feb. 25, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Marc Stapley Chief Financial Officer — Rebecca Chambers Chief Commercial Officer — Dr. John Leite Chief Medical and Scientific Officer — Dr. Phillip G. Febbo Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conference Call Transcript Marc Stapley, Veracyte, Inc.'s Chief Executive Officer, and Rebecca Chambers, our Chief Financial Officer. Dr. John Leite, our Chief Commercial Officer, and Dr. Phillip G. Febbo, our Chief Medical and Scientific Officer, will join us for Q&A. Veracyte, Inc. issued a press release earlier this afternoon detailing our fourth quarter and full-year 2025 financial results. This release and a copy of the presentation we will review during the call today are available in the Investors section of our website at veracyte.com. Before we begin, I would like to remind you that statements we make during this call
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte (VCYT) had its price target raised by Needham & Company LLC from $44.00 to $48.00. They now have a "buy" rating on the stock.MarketBeat
- Veracyte Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Veracyte outlines 10%–13% revenue growth for 2026 while advancing MRD and Prosigna launches [Seeking Alpha]Seeking Alpha
- Veracyte: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Veracyte Announces Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
VCYT
Earnings
- 2/25/26 - Beat
VCYT
Sec Filings
- 2/26/26 - Form 10-K
- 2/25/26 - Form 8-K
- 2/5/26 - Form SCHEDULE
- VCYT's page on the SEC website